ArticleCrohn's & colitis 3602026
Confirming the association of ulcerative colitis with interstitial lung disease: a retrospective analysis of comorbid disease, demographics, and healthcare utilization.
Article in Crohn's & colitis 360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut microbiome-driven mechanisms in inflammatory bowel disease-associated interstitial lung disease: from dysbiosis to therapeutic implications.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Interstitial lung disease (ILD) is a rare extraintestinal manifestation associated with inflammatory bowel disease (IBD). Limited information is available regarding the prevalence and risk factors of ILD in IBD. This study aimed to determine the association of ILD in Crohn's disease (CD) and ulcerative colitis (UC), while analyzing various contributory factors. Methods: A retrospective analysis of patient data at two major tertiary healthcare centers in the southeastern United States from 2012 to 2022 was conducted. Patient demographics, healthcare utilization patterns, and coexisting diagnoses of IBD and ILD were analyzed using comparative statistical analysis. Results: A total of 8865 IBD patients were included in the study, of which 408 (4.6%) had concomitant IBD and ILD. Patients with UC had a significantly higher prevalence of ILD compared to those with CD ( Conclusions: Our findings confirm the established literature that ILD is more associated with UC compared to CD, while providing new insight into demographic and healthcare utilization factors between CD-ILD and UC-ILD patients and between IBD-ILD compared to IBD-only patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.